| Literature DB >> 36246945 |
Miki Sato-Akushichi1, Reiko Kinouchi1,2, Satoshi Ishiko1,2, Kazuomi Hanada2, Hiroki Hayashi2, Daiki Mikami2, Shinji Ono1, Yasuo Yanagi1.
Abstract
Purpose: To elucidate the prevalence of soft drusen, pseudodrusen, and pachydrusen and their 5-year changes in a Japanese population. Design: Longitudinal population-based cohort study conducted from 2013 through 2017. Participants: Residents 40 years of age or older.Entities:
Keywords: AMD, age-related macular degeneration; CFP, color fundus photograph; CI, confidence interval; Drusen subtypes; GA, geographic atrophy; Longitudinal changes; OCT, optical coherene tomography; Pachydrusen; Population-based cohort study; RPE, retinal pigment epithelium
Year: 2021 PMID: 36246945 PMCID: PMC9560559 DOI: 10.1016/j.xops.2021.100081
Source DB: PubMed Journal: Ophthalmol Sci ISSN: 2666-9145
Figure 1Representative color fundus photographs (CFPs) of each drusen subtype and pigment abnormality. A, Soft drusen. The CFP shows round or ovoid deposits with a poorly defined border; they can be tightly packed and confluent in the center of the macula. B, Pseudodrusen. The CFP shows whitish deposits scattered with irregular outer contours that do not involve the central macula and a characteristic reticular pattern. C, Pachydrusen. The CFP shows yellow-white deposits, which have an ovoid or more complex and well-defined irregular outer border compared with soft drusen and are present in isolated or scattered patterns anywhere in the temporal vascular arcades. D, Pigment abnormalities. The CFP shows hyperpigmentation at the center of the macula.
Participants’ Baseline Characteristics
| Characteristic | Total (n = 1660) | Early Age-Related Macular Degeneration | Unadjusted | |
|---|---|---|---|---|
| Present (n = 194) | Absent (n = 1466) | |||
| Age (yrs) | 57.6 ± 10.9 | 63.8 ± 9.7 | 56.8 ± 10.8 | <0.001 |
| Male sex | 57.5 (955) | 58.2 (113) | 57.4 (842) | 0.877 |
| BMI (kg/m2) | 24.2 ± 3.8 | 23.8 ± 3.4 | 24.2 ± 3.8 | 0.185 |
| Diabetes mellitus | 6.5 (107) | 5.2 (10) | 6.6 (97) | 0.534 |
| Hypertension | 20.2 (335) | 25.3 (49) | 19.5 (286) | 0.070 |
BMI = body mass index.
Data are presented as mean ± standard deviation or percentage (no.). Results from multivariate regression analysis are shown in Supplemental Table 1.
Wilcoxon rank-sum test.
Fisher exact test.
Prevalence of Each Drusen Subtype
| Soft Drusen | Pachydrusen | Pseudodrusen | Pigment Abnormalities | Late Age-Related Macular Degeneration | |
|---|---|---|---|---|---|
| Crude prevalence | |||||
| Age group (yrs) | |||||
| 40–49 (n = 457) | 1.8 (8) | 2.2 (10) | 0.0 (0) | 0.9 (4) | 0 (0) |
| 50–59 (n = 479) | 2.9 (14) | 6.7 (32) | 0.2 (1) | 1.7 (8) | 0 (0) |
| 60–69 (n = 469) | 4.7 (22) | 8.3 (39) | 1.5 (7) | 3.2 (15) | 0.2 (1) |
| 70+ (n = 255) | 6.3 (16) | 11.0 (28) | 6.7 (17) | 3.9 (10) | 0 (0) |
| Total 40+ (n = 1660) | 3.6 (60) | 6.6 (109) | 1.5 (25) | 2.2 (37) | 0.06 (1) |
| Total 50+ (n = 1203) | 4.3 (52) | 8.2 (99) | 2.1 (25) | 2.7 (33) | 0.08 (1) |
| | <0.001 | <0.001 | <0.001 | 0.002 | |
| Sex | |||||
| Male 40 + (n = 955) | 4.3 (41) | 6.9 (66) | 0.6 (6) | 2.7 (26) | 0.1 (1) |
| Female 40+ (n = 705) | 2.7 (19) | 6.1 (43) | 2.7 (19) | 1.6 (11) | 0 (0) |
| | 0.024 | 0.160 | 0.046 | 0.044 | |
| Extramacular regions only (n = 61) | 6.6 (4) | 82.0 (50) | 11.5 (7) | ||
| Age-adjusted prevalence (yrs) | |||||
| All 40+ | 4.3 (3.2–5.8) | 7.7 (6.2–9.7) | 2.8 (1.7–4.2) | 2.7 (1.8–4.0) | 0.06 (0.001–0.6) |
| All 50+ | 5.0 (3.5–6.8) | 9.1 (7.2–11.4) | 3.4 (2.2–5.2) | 3.1 (2.0–4.7) | 0.07 (0.002–0.7) |
| Men 40+ | 5.2 (3.5–7.6) | 8.4 (6.2–11.3) | 1.5 (0.5–3.4) | 3.1 (1.9–5.0) | 0.11 (0.003–1.2) |
| Men 50+ | 6.1 (4.0–9.2) | 10.0 (7.2–13.7) | 2.0 (0.7–4.4) | 3.7 (2.2–6.2) | 0.14 (0.004–1.5) |
| Women 40+ | 3.3 (1.9–5.5) | 7.0 (4.9–9.8) | 3.9 (2.3–6.4) | 2.1 (1.0–4.1) | 0 % (0–1.0) |
| Women 50+ | 3.7 (2.1–6.3) | 8.2 (5.7–11.5) | 4.8 (2.8–7.7) | 2.5 (1.1–4.8) | 0 % (0–1.2) |
Data are presented as percentage (no.) or percentage (95% confidence interval).
Cochran-Armitage test.
Cochran-Mantel-Haenszel test.
Standardized to the age distribution of the Rumoi city population.
Longitudinal Changes of Drusen
| Variable | Increase in Size | Regression | No Changes | Development of Conditions Other Than Age-Related Macular Degeneration | No Follow-up Data |
|---|---|---|---|---|---|
| Soft drusen (n = 60) | 8.3 (5) | 1.7 (1) | 71.7 (43) | 3.3 (2) | 15.0 (9) |
| <O2 circle (n = 30) | 3.3 (1) | 0 (0) | 76.7 (23) | 0 (0) | 20 (6) |
| ≥O2 circle (n = 30) | 13.3 (4) | 3.3 (1) | 66.7 (20) | 6.7 (2) | 10 (3) |
| Pachydrusen (n = 109) | 3.7 (4) | 5.5 (6) | 77.1 (84) | 1.8 (2) | 11.9 (13) |
| <O2 circle (n = 73) | 4.1 (3) | 4.1 (3) | 78.1 (57) | 2.7 (2) | 11.0 (8) |
| ≥O2 circle (n = 36) | 2.8 (1) | 8.3 (3) | 75.0 (27) | 0 (0) | 13.9 (5) |
| Pseudodrusen (n = 25) | 8.0 (2) | 0 (0) | 72.0 (18) | 8.0 (2) | 12.0 (3) |
Data are presented as percentage (no.).
Branch retinal vein occlusion in all 6 eyes.
Figure 2Color fundus photographs showing longitudinal changes of drusen. A, B, Longitudinal changes of soft drusen (A) at baseline, with a total drusen area smaller than an O2 circle, are seen in the macula that (B) increased in size during the 5-year follow-up period. C, D, Longitudinal changes of pachydrusen (C) at baseline and (D) at year 5. At baseline, a large, irregular, well-defined yellow pachydrusen is seen at the nasal-inferior part of the macula (white arrow). The margin became a little blurred and color became slightly lighter at year 1, and then it disappeared without leaving any signs of retinal pigment epithelium atrophy at year 2. No apparent sign of atrophy is present at the corresponding region at year 5 (white arrow).